Day BW - Search Results

1

A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.

Nguyen TL, McGrath C, Hermone AR, Burnett JC, Zaharevitz DW, Day BW, Wipf P, Hamel E, Gussio R. Nguyen TL, et al. Among authors: day bw. J Med Chem. 2005 Sep 22;48(19):6107-16. doi: 10.1021/jm050502t. J Med Chem. 2005. PMID: 16162011

2

Synthesis and biological evaluation of structurally highly modified analogues of the antimitotic natural product curacin A.

Wipf P, Reeves JT, Balachandran R, Day BW. Wipf P, et al. Among authors: day bw. J Med Chem. 2002 Apr 25;45(9):1901-17. doi: 10.1021/jm0105171. J Med Chem. 2002. PMID: 11960501

3

Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.

ter Haar E, Rosenkranz HS, Hamel E, Day BW. ter Haar E, et al. Among authors: day bw. Bioorg Med Chem. 1996 Oct;4(10):1659-71. doi: 10.1016/0968-0896(96)00158-7. Bioorg Med Chem. 1996. PMID: 8931935

4

Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.

Verdier-Pinard P, Lai JY, Yoo HD, Yu J, Marquez B, Nagle DG, Nambu M, White JD, Falck JR, Gerwick WH, Day BW, Hamel E. Verdier-Pinard P, et al. Among authors: day bw. Mol Pharmacol. 1998 Jan;53(1):62-76. doi: 10.1124/mol.53.1.62. Mol Pharmacol. 1998. PMID: 9443933

5

Chemistry and biology of curacin A.

Wipf P, Reeves JT, Day BW. Wipf P, et al. Among authors: day bw. Curr Pharm Des. 2004;10(12):1417-37. doi: 10.2174/1381612043384853. Curr Pharm Des. 2004. PMID: 15134491 Review.

6

Synthesis and biological evaluation of 1,1-dichloro-2,3-diarylcyclopropanes as antitubulin and anti-breast cancer agents.

Jonnalagadda SS, ter Haar E, Hamel E, Lin CM, Magarian RA, Day BW. Jonnalagadda SS, et al. Among authors: day bw. Bioorg Med Chem. 1997 Apr;5(4):715-22. doi: 10.1016/s0968-0896(97)00014-x. Bioorg Med Chem. 1997. PMID: 9158870

7

Biphenyl C-cyclopropylalkylamides: New scaffolds for targeting estrogen receptor beta.

Sarachine MJ, Janjic JM, Wipf P, Day BW. Sarachine MJ, et al. Among authors: day bw. Bioorg Med Chem Lett. 2009 May 1;19(9):2404-8. doi: 10.1016/j.bmcl.2009.03.075. Epub 2009 Mar 25. Bioorg Med Chem Lett. 2009. PMID: 19356928 Free PMC article.

8

New antiestrogens from a library screen of homoallylic amides, allylic amides, and C-cyclopropylalkylamides.

Janjic JM, Mu Y, Kendall C, Stephenson CR, Balachandran R, Raccor BS, Lu Y, Zhu G, Xie W, Wipf P, Day BW. Janjic JM, et al. Among authors: day bw. Bioorg Med Chem. 2005 Jan 3;13(1):157-64. doi: 10.1016/j.bmc.2004.09.048. Bioorg Med Chem. 2005. PMID: 15582460

9

New opportunities for pregnane X receptor (PXR) targeting in drug development. lessons from Enantio- and species-specific PXR ligands identified from a discovery library of amino acid analogues.

Wipf P, Gong H, Janjic JM, Li S, Day BW, Xie W. Wipf P, et al. Among authors: day bw. Mini Rev Med Chem. 2007 Jun;7(6):617-25. doi: 10.2174/138955707780859404. Mini Rev Med Chem. 2007. PMID: 17584160 Review.

10

Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly.

Hamel E, Day BW, Miller JH, Jung MK, Northcote PT, Ghosh AK, Curran DP, Cushman M, Nicolaou KC, Paterson I, Sorensen EJ. Hamel E, et al. Among authors: day bw. Mol Pharmacol. 2006 Nov;70(5):1555-64. doi: 10.1124/mol.106.027847. Epub 2006 Aug 3. Mol Pharmacol. 2006. PMID: 16887932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters